Bio-Techne Corp (TECH) support and resistance
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
This page maps Bio-Techne Corp (TECH) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TECH 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TECH quote page for the session range and the stock page for the full model.
Not investment advice.